The research focuses on , a targeted drug delivery system. It uses complex plant oligosaccharides (like xyloglucan) to "cage" drugs, ensuring they are only released in the gut by specific bacterial enzymes. This prevents off-target side effects and increases the efficacy of anti-inflammatory treatments for conditions like Inflammatory Bowel Disease (IBD). Why "tca.7z"?
: Drugs are activated by glycosidases produced by local gut bacteria, making the treatment highly site-specific.
: By keeping the drug inactive until it reaches the colon, the system eliminates systemic side effects typically seen with steroids or anti-inflammatory drugs.